1588 related articles for article (PubMed ID: 18079166)
1. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy.
Orimo S; Kanazawa T; Nakamura A; Uchihara T; Mori F; Kakita A; Wakabayashi K; Takahashi H
Acta Neuropathol; 2007 Jan; 113(1):81-6. PubMed ID: 17089131
[TBL] [Abstract][Full Text] [Related]
4. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease.
Orimo S; Uchihara T; Kanazawa T; Itoh Y; Wakabayashi K; Kakita A; Takahashi H
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):791-802. PubMed ID: 21696416
[TBL] [Abstract][Full Text] [Related]
5. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
[TBL] [Abstract][Full Text] [Related]
6. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study.
Ghebremedhin E; Del Tredici K; Langston JW; Braak H
Acta Neuropathol; 2009 Dec; 118(6):777-84. PubMed ID: 19802627
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Nov; 48(11):831-4. PubMed ID: 19198094
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.
Isonaka R; Sullivan P; Jinsmaa Y; Corrales A; Goldstein DS
Clin Auton Res; 2018 Apr; 28(2):223-230. PubMed ID: 29396794
[TBL] [Abstract][Full Text] [Related]
9. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
Cersosimo MG; Benarroch EE
J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
[TBL] [Abstract][Full Text] [Related]
11. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease.
Orimo S; Takahashi A; Uchihara T; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain Pathol; 2007 Jan; 17(1):24-30. PubMed ID: 17493034
[TBL] [Abstract][Full Text] [Related]
12. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
13. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
14. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
16. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism.
Navarro-Otano J; Gelpi E; Mestres CA; Quintana E; Rauek S; Ribalta T; Santiago V; Tolosa E
Parkinsonism Relat Disord; 2013 Jan; 19(1):27-31; discussion 27. PubMed ID: 22858179
[TBL] [Abstract][Full Text] [Related]
18. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
[TBL] [Abstract][Full Text] [Related]
20. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
Minguez-Castellanos A; Chamorro CE; Escamilla-Sevilla F; Ortega-Moreno A; Rebollo AC; Gomez-Rio M; Concha A; Munoz DG
Neurology; 2007 Jun; 68(23):2012-8. PubMed ID: 17548551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
